These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 230269)

  • 1. Receptor-mediated low density lipoprotein catabolism in man.
    Shepherd J; Bicker S; Lorimer AR; Packard CJ
    J Lipid Res; 1979 Nov; 20(8):999-1006. PubMed ID: 230269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low density lipoprotein metabolism in the normal to moderately elevated range of plasma cholesterol: comparisons with familial hypercholesterolemia.
    Simons LA; Balasubramaniam S; Holland J
    J Lipid Res; 1983 Feb; 24(2):192-9. PubMed ID: 6572682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.
    Bilheimer DW; Stone NJ; Grundy SM
    J Clin Invest; 1979 Aug; 64(2):524-33. PubMed ID: 222811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism.
    Shepherd J; Packard CJ; Bicker S; Lawrie TD; Morgan HG
    N Engl J Med; 1980 May; 302(22):1219-22. PubMed ID: 7366673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholestyramine on receptor-mediated plasma clearance and tissue uptake of human low density lipoproteins in the rabbit.
    Slater HR; Packard CJ; Bicker S; Shepherd J
    J Biol Chem; 1980 Nov; 255(21):10210-3. PubMed ID: 6253466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins.
    Gaw A; Packard CJ; Lindsay GM; Griffin BA; Caslake MJ; Lorimer AR; Shepherd J
    J Lipid Res; 1995 Jan; 36(1):158-71. PubMed ID: 7706941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 1,2-cyclohexanedione modification on the metabolism of very low density lipoprotein apolipoprotein B: potential role of receptors in intermediate density lipoprotein catabolism.
    Packard CJ; Boag DE; Clegg R; Bedford D; Shepherd J
    J Lipid Res; 1985 Sep; 26(9):1058-67. PubMed ID: 4067428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo clearance of low-density lipoproteins and beta-very-low-density lipoproteins in normal and hypercholesterolemic White Carneau pigeons.
    Reagan JW; St Clair RW
    Biochim Biophys Acta; 1991 Jan; 1081(2):202-10. PubMed ID: 1998739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia.
    Caslake MJ; Packard CJ; Gaw A; Murray E; Griffin BA; Vallance BD; Shepherd J
    Arterioscler Thromb; 1993 May; 13(5):702-11. PubMed ID: 8485122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
    Brunzell JD; Albers JJ; Chait A; Grundy SM; Groszek E; McDonald GB
    J Lipid Res; 1983 Feb; 24(2):147-55. PubMed ID: 6403642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ciprofibrate on LDL metabolism in man.
    Gaw A; Packard CJ; Caslake MJ; Griffin BA; Lindsay GM; Thomson J; Vallance BD; Wosornu D; Shepherd J
    Atherosclerosis; 1994 Aug; 108(2):137-48. PubMed ID: 7980713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease.
    Schaefer EJ; Blum CB; Levy RI; Jenkins LL; Alaupovic P; Foster DM; Brewer HB
    N Engl J Med; 1978 Oct; 299(17):905-10. PubMed ID: 211412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
    Sigurdsson G; Nicoll A; Lewis B
    J Clin Invest; 1975 Dec; 56(6):1481-90. PubMed ID: 172533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein.
    Huff MW; Telford DE
    Arteriosclerosis; 1989; 9(1):58-66. PubMed ID: 2912422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects.
    Stewart JM; Packard CJ; Lorimer AR; Boag DE; Shepherd J
    Atherosclerosis; 1982 Sep; 44(3):355-65. PubMed ID: 6293516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catabolism of very low density lipoprotein B apoprotein in man.
    Reardon MF; Fidge NH; Nestel PJ
    J Clin Invest; 1978 Mar; 61(3):850-60. PubMed ID: 205554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma triglyceride and low density lipoprotein metabolism.
    Caslake MJ; Packard CJ; Series JJ; Yip B; Dagen MM; Shepherd J
    Eur J Clin Invest; 1992 Feb; 22(2):96-104. PubMed ID: 1572392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ileal exclusion on kinetics of very low density lipoprotein triglycerides in familial hypercholesterolemia.
    Koivisto PV; Miettinen TA
    Clin Chim Acta; 1986 Nov; 161(1):91-101. PubMed ID: 3815857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.